Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival.
Di Lullo G, Marcatti M, Heltai S, Brunetto E, Tresoldi C, Bondanza A, Bonini C, Ponzoni M, Tonon G, Ciceri F, Bordignon C, Protti MP.
Di Lullo G, et al. Among authors: protti mp.
Oncoimmunology. 2015 Feb 3;4(5):e1005460. doi: 10.1080/2162402X.2015.1005460. eCollection 2015 May.
Oncoimmunology. 2015.
PMID: 26155400
Free PMC article.